It is a serious condition that can have a significant impact on children’s and adolescents’ lives. This condition can have a significant impact on the academic performance and social functioning of children. Fluoxetine is an FDA-approved medication that may be prescribed by therapists for the treatment of patients. Sertraline, another medication that is available to patients, can also be prescribed. Sertraline can be used for OCD and is therefore considered off-label. Cognitive Behavioral Therapy is a non-pharmacological treatment of persistent depressive disorder that’s recommended by most psychologists. It is highly effective and has low risks. CBT, Sertraline and Fluoxetine are effective in decreasing the negative effects of persistent depression illness. This is dependent on therapeutic standards and risk assessments.
Threat Analysis and Recommendations
For patients, fluoxetine’s extended half-life is a benefit. People who frequently forget to take their medicine (Mullen (2018)) will find this useful. It takes fluoxetine longer to reach stability than antidepressants. Fluoxetine can cause suicidal thoughts in some patients and may increase aggression or anxiety. (Neavin, et al. (2018) People with persistent depressive illnesses are already at high risk for suicide, so the risks associated with Fluoxetine can’t be considered greater than the potential dangers of not getting treatment.
Because of the potential suicide risks associated with fluoxetine, FDA advises biweekly, monthly, and weekly patient monitoring. A lot of fluoxetine-related substance abuse is seen in young children. Mullen (2018) asserts that adolescents and children are much more susceptible to experiencing withdrawal symptoms than adults. Because of its long half-life, many hazards are mitigated. Prescription adherence is a priority when using this drug (Mullen (2018) Additional side effects include mania, addiction, weight loss, and decreased height relative to others. The persistence of fluoxetine in the body of the patient is crucial for relieving the symptoms of persistent depression.
The FDA has approved Sertraline for OCD treatment in adults over six years. The FDA has not approved the prescription medication for chronic depression. Because of its effectiveness and acceptance, the medicine can be beneficial for depression treatment (Tini and al., 2002). Sertraline use is not recommended for children. There has not been enough research on Sertraline’s effectiveness in treating depression in both children and adults. Sertraline, which is a member the SSRIs (Selective Serotonin Reuptake Ihibitors), impedes serotonin reabsorption. Although the risks are minimal, unpleasant side effects include aggression, disorientation, sleep disruption, blood loss, sleep disturbance and nausea. Sertraline withdrawal is generally responsible for the majority of negative symptoms. SSRIs are not recommended to be combined with anticoagulants as they can increase the risk of bleeding.
The combination of medication and CBT could be combined with CBT to help treat persistent depression disorder. Easden and Fletcher (2020) define CBT as a method for treating depression that relies on empirically-supported facts.
Order an Essay Now & Get These Features For Free:
Turnitin Report
Formatting
Title Page
Citation
Outline
